Charles River Laboratories CRL Gain on sale of business and assets
Gain on sale of business and assets at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's gain on sale of business and assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's gain on sale of business and assets?
- Charles River Laboratories (CRL) reported gain on sale of business and assets of -$117.98M in Q1 2026.
- How has Charles River Laboratories's gain on sale of business and assets changed year-over-year?
- Charles River Laboratories's gain on sale of business and assets decreased by 3594.7% year-over-year, from $3.38M to -$117.98M.
- What is the long-term trend for Charles River Laboratories's gain on sale of business and assets?
- Over 2 years (2021 to 2023), Charles River Laboratories's gain on sale of business and assets has grown at a -80.1% compound annual growth rate (CAGR), from $25.03M to -$995K.